Lemon Extract,Lemon Extract Powder,Natural Lemon Extract,Pure Lemon Extract NANJING ZELANG MEDICAL TECHONOLOGY CO., LTD , https://www.hawfitness.com
The drug, called ticagrelor, is being evaluated by the US Food and Drug Administration (FDA) and will compete with Plavix, which is sold in partnership with Bristol-Myers Squibb (BMY) and Sanofi-Aventis (SNY).
The substudy was conducted in patients with genetic variants, and studies have shown that platelet levels in these patients are maintained despite genetic differences. AstraZeneca said previous studies have shown that these differences affect the patient's response to Plavix.
Ticagrelor's findings were announced at the Europeanean Oceanic Society of Cardiology Congress in Stockholm on Sunday.
AstraZeneca anticoagulant reaches key research goals
On the evening of August 30th, Beijing time, AstraZeneca (AZN) said that a potential anticoagulant drug developed in a genetic sub-study for heart disease patients reached key research goals.